Zhejiang Clover Biopharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Zhejiang Clover Biopharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China (NCT04954131) | Zhejiang Clover Biopharmaceuticals, Inc. | 2021-08-10 |
Track Zhejiang Clover Biopharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.